About Stantech Pharmaceuticals Private Limited
Data last updated:
Stantech Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Sydler Remedies Private Limited. It operates in the IT products retail and distribution segment of the technology and IT services sector. It was incorporated on 26 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC153516. Its GSTIN is 27AAJCS0316B1ZU (Maharashtra). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹75,010. It is led by directors including Pankaj Rajkumar Yambal and Rohit Rajkumar Yambal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.91 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹12.6 Lakh (net margin 0.4%) and EBITDA of ₹3.93 Cr (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.44 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stantechpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOffice No – 3 To 6 7th Floor Arcadia Building 195 Ncpa Marg Narima, N Point, Mumbai, Maharashtra, India – 400021
- IndustryInformation Technology, IT Products Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Stantech Pharmaceuticals Private Limited
The main business activity of Stantech Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stantech Pharmaceuticals Private Limited FY 2024 filings available
Stantech Pharmaceuticals Private Limited reported revenue of ₹28.91 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Stantech Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 17% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stantech Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.93 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.6 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stantech Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stantech Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Information Technology industry (IT Products Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Micro Access Private Limited | ₹28.98 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Rajkot, Gujarat, India |
| Monique Pharmaceuticals Private Limited | ₹28.97 Cr (FY 2024) | •••• | •••• | -51.0% | •••• | New Delhi, Delhi, India |
| Valson's Computers Private Limited | ₹28.94 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Surat, Gujarat, India |
| SGS Info Solutions Private Limited | ₹28.93 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Delhi, India |
| Softek Office Products Private Limited. | ₹28.92 Cr (FY 2024) | •••• | •••• | 118.0% | •••• | New Delhi, Delhi, India |
| Stantech Pharmaceuticals Private Limited this company | ₹28.91 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Meenakshi Ayurvedic Private Limited | ₹28.88 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Delhi, India |
| Sun Micro Invit Private Limited | ₹28.88 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Delhi, India |
| Goel Vet Pharma Private Limited | ₹28.84 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Chittorgarh, Rajasthan, India |
| Dycine Pharmaceuticals Limited | ₹28.83 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Noida, Uttar Pradesh, India |
| Image Star Private Limited | ₹28.8 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Stantech Pharmaceuticals by revenue in the Information Technology industry (IT Products Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals Private Limited is audited by Darshan Bheda & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Darshan Bheda & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Rajkumar Yambal | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
| Rohit Rajkumar Yambal Also directs: Sydler Remedies Private Limited, Sydler Technologies Private Limited, Balaji Telefilms Limited and 1 more | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
| Swati Pankaj Jain | Additional Director | 18 Dec 2021 | 4 Years 9 Months | Current |
Ownership and Shareholding of Stantech Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stantech Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2021 | Others | ₹12.44 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals Private Limited has a workforce of 24 employees as of Oct 10, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals Private Limited has 9 board changes on record since 2009: 3 appointments and 6 cessations. The latest: Swati Pankaj Jain was appointed as Additional Director on 18 Dec 2021.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Stantech Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stantech Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stantech Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCS0316B1ZU | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stantech Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stantech Pharmaceuticals Private Limited
Stantech Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in IT products retail and distribution, within the information technology industry. It was incorporated on 26 May 2005 (21+ years old) and is registered under CIN U24230MH2005PTC153516.
Stantech Pharmaceuticals reported revenue of ₹28.91 Cr for FY 2024 (up 17% YoY).
Stantech Pharmaceuticals has 3 current directors:
- Pankaj Rajkumar Yambal - Director
- Rohit Rajkumar Yambal - Director
- Swati Pankaj Jain - Additional Director
Stantech Pharmaceuticals reported a net profit of ₹12.6 Lakh (net margin 0.4%) and EBITDA of ₹3.93 Cr (EBITDA margin 13.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stantech Pharmaceuticals is -3% over three years and 1% over five years. In the latest year (FY 2024) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stantech Pharmaceuticals is 27AAJCS0316B1ZU, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Stantech Pharmaceuticals is U24230MH2005PTC153516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stantech Pharmaceuticals was incorporated on 26 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Stantech Pharmaceuticals by revenue are Micro Access Private Limited, Monique Pharmaceuticals Private Limited, Valson's Computers Private Limited, SGS Info Solutions Private Limited, Softek Office Products Private Limited. and 5 more, all in the Information Technology industry (IT Products Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals).
Swati Pankaj Jain was appointed as Additional Director on 18 Dec 2021. Pankaj Rajkumar Yambal ceased to be Additional Director on 31 Dec 2020. Rohit Rajkumar Yambal ceased to be Additional Director on 31 Dec 2020. Stantech Pharmaceuticals has 9 board changes on record in total.
Stantech Pharmaceuticals can be reached through the website stantechpharma.com. Its registered office is in Mumbai, Maharashtra, India.